← Back to Search

Behavioural Intervention

Smartwatch Biofeedback for Intimate Partner Violence (START Trial)

N/A
Waitlist Available
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least one partner within each dyad must meet DSM-V diagnostic criteria for current AUD (assessed by the QuickSCID) and consume ≥ 2 hazardous drinking episodes (i.e., 4 or more drinks for women, 5 or more for men in ≤ 2 hours) per month in the past three months
Be older than 18 years old
Must not have
Serious cardiovascular health conditions (e.g., pacemaker, cardiac arrhythmia, hypertension) because the safety of HRV-B has not yet been established in these populations
Current neurologic conditions or history of traumatic brain injury
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days
Awards & highlights
No Placebo-Only Group

Summary

This trial uses smartwatches and a mobile app to help couples dealing with alcohol use disorder (AUD) and intimate partner violence (IPV). The smartwatch tracks heart rate changes to monitor stress, while the app provides feedback to help manage stress and reduce alcohol cravings.

Who is the study for?
This trial is for couples aged 21-70 where at least one partner has been involved in intimate partner violence (IPV) and meets criteria for alcohol use disorder (AUD). Participants must be fluent in English, mentally capable of consent, and have stable psychotropic medication if applicable. Couples should not have severe cardiovascular conditions, current pregnancy, acute alcohol withdrawal, suicidal or homicidal thoughts, certain medications affecting heart rate, severe brain injuries or unilateral IPV.
What is being tested?
The study tests a smartwatch device with Heart Rate Variability-Biofeedback (HRV-B) and a cell phone app to see if they can help reduce alcohol consumption and conflict among couples. Over a period of 28 days, participants will wear the smartwatch to monitor their activities while using the app designed to support treatment.
What are the potential side effects?
Since this intervention involves wearable technology rather than medication or invasive procedures, side effects are minimal but may include discomfort from wearing the device or stress from monitoring symptoms.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I or my partner have been diagnosed with alcohol use disorder and have had multiple heavy drinking episodes recently.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have serious heart conditions like arrhythmia or high blood pressure.
Select...
I have a neurological condition or a history of traumatic brain injury.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability of Heart Rate Variability-Biofeedback Intervention
Feasibility of Heart Rate Variability-Biofeedback Intervention
Heart Rate Variability in Alcohol-Facilitated Intimate Partner Violence
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Heart Rate Variability-Biofeedback via Smartwatch Device InterventionExperimental Treatment1 Intervention
Participants will wear activity trackers equipped with continuous ambulatory physiological monitoring and geolocation. Ecological momentary assessment (EMA; 4 times daily plus optional event-triggered reports) of alcohol use, couple conflict including IPV, and affect will be completed via smartphone application for 28 days. During days 21-28, participants will also be prompted to complete a 10 minute self-administered HRV-B session at least once daily. Subjective usability, feasibility, and acceptability of HRV-B will be assessed.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for couples, such as time-limited psychodynamic psychotherapy and behavioral interventions using wearable activity trackers and cell phone applications, focus on improving communication, emotional understanding, and conflict resolution. The mechanisms of action for these treatments often involve real-time monitoring and feedback, which help couples become more aware of their behaviors and emotional responses. This increased awareness can lead to more constructive interactions and a deeper understanding of each other's needs and perspectives. For couples, these mechanisms are crucial as they provide tangible data and insights that can facilitate positive changes in their relationship dynamics.
Electronic behavioral interventions for headache: a systematic review.An evaluation of time-limited psychodynamic psychotherapy for couples: a pilot study.

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
972 Previous Clinical Trials
7,399,210 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,812 Previous Clinical Trials
8,161,379 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
835 Previous Clinical Trials
1,082,678 Total Patients Enrolled

Media Library

Heart Rate Variability Intervention (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05374798 — N/A
Couples Research Study Groups: Heart Rate Variability-Biofeedback via Smartwatch Device Intervention
Couples Clinical Trial 2023: Heart Rate Variability Intervention Highlights & Side Effects. Trial Name: NCT05374798 — N/A
Heart Rate Variability Intervention (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05374798 — N/A
~33 spots leftby Nov 2025